Aida Pharmaceuticals (AIDA)

[PaperProphet]

Yes, they said they were compiling the Rh-APO2L phase II data back in April and were going to publish the results a month from then. It's been over three months since then.

I wonder what the issue is.

The R&D expenses were somewhat higher in the second quarter than the first quarter and the 10-Q says R&D for the three- and six-month periods mainly represents costs incurred for clinical trials of Rh-APO2L. That's after they announced in late April that they were compiling the phase II data. That might mean that it hasn't been abandoned.